Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-02-01 @ 10:23 PM
Study NCT ID:
NCT03959150
Status:
UNKNOWN
Last Update Posted:
2021-04-30
First Post:
2019-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer
Sponsor:
Ruijin Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Metro-PC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None